Mon panier

IL-13 R alpha 2

IL-13 R alpha 2 Informations sur la molécule

Nom anglaisInterleukin-13 receptor subunit alpha-2Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9Alias de la cibleInterleukin 13 Receptor Alpha 2 Chain,Interleukin-13 Receptor alpha2 Subunit,IL-13RA2,IL-13R-alpha-2,Interleukin-13-binding protein,IL13RA2,Interleukin 13 Receptor Subunit Alpha 2,Interleukin 13 Receptor, Alpha 2,IL-13 Receptor Subunit Alpha-2,Cancer/Testis Antigen 19,IL-13R Subunit Alpha-2,Interleukin-13 Receptor Subunit Alpha-2,Interleukin 13 Binding Protein,CD213a2 Antigen,CD213A2,IL-13R,IL13BP,IL13R,CT19
Phase de R&D la plus avancéePhase 1 Clinical
Nom anglaisInterleukin-13 receptor subunit alpha-2
Alias de la cibleInterleukin 13 Receptor Alpha 2 Chain,Interleukin-13 Receptor alpha2 Subunit,IL-13RA2,IL-13R-alpha-2,Interleukin-13-binding protein,IL13RA2,Interleukin 13 Receptor Subunit Alpha 2,Interleukin 13 Receptor, Alpha 2,IL-13 Receptor Subunit Alpha-2,Cancer/Testis Antigen 19,IL-13R Subunit Alpha-2,Interleukin-13 Receptor Subunit Alpha-2,Interleukin 13 Binding Protein,CD213a2 Antigen,CD213A2,IL-13R,IL13BP,IL13R,CT19
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9
Phase de R&D la plus avancéePhase 1 Clinical

IL-13 R alpha 2 Liste de produits

  • Attribut

    Protein (8)

  • Bibliothèque de produits

    En ligne (8)

  • Espèces

    Human (4)Rhesus macaque (1)Canine (1)Mouse (2)

  • Étiquette

    His Tag (5)Fc Tag (2)His Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (6)FITC Labeled (1)Biotin-labeled (1)

IL-13 R alpha 2Contexte de la molécule

Interleukin-13 receptor subunit alpha-2 is also known as IL13Rα2, IL13Ra2 cluster of differentiation 213A2, CD213A2, CT19, IL-13R, IL13BP, and is a membrane bound protein that in humans is encoded by the IL13RA2 gene. IL13Rα2 is closely related to IL13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however able to regulate the effects of both IL13 and IL4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13. IL13Rα2 is a component of the cell surface receptors, however, the majority exists in intracellular pools and in soluble form, and thus plays an opposite role as a potent IL13 antagonist compared with IL13Rα1. It also functions as an inhibitor of IL4-dependent pathway probably through the physical interaction between the short intracellular domain of and cytoplasmic domain of IL13Rα2 and the IL4Rα chain. In spite of the failed STAT signaling function, IL13Rα2 dose induce TGF-beta production and fibrosis. Additionally, IL13Rα2has been reported to be abundantly and specifically overexpressed in glioblastoma multiforme.

IL-13 R alpha 2Alias de la molécule

IL13RA2,CD213A2,CT19,IL-13R,IL13BP

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
MB-101 (Mustang Bio)MB-101Phase 1 ClinicalCity Of Hope National Medical Center, Mustang Bio IncBrain Neoplasms; CNS Embryonal Tumor; Glioblastoma; Glioma
Details
IL13Ralpha2 CAR-T cell therapy (Jonsson Comprehensive Cancer Center)Phase 1 ClinicalUclas Jonsson Comprehensive Cancer CenterAdenocarcinoma of Lung; Adenoma, Islet Cell; Adrenocortical Carcinoma; Breast Neoplasms; Ependymoma; Glioblastoma; Medulloblastoma; Melanoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uveal melanoma
Details
E-Sync T Cell Therapy (University of California/National Cancer Institute/California Institute for Regenerative Medicine)Phase 1 ClinicalUniversity Of California San FranciscoGlioblastoma
Details
EPC-003EPC-003Phase 1 ClinicalElpis BioPharmaceuticals CorpGlioblastoma; Multiple Myeloma
Details
IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody therapy (Emergency General Hospital)Phase 1 ClinicalEmergency General Hospital, Department of NeurosurgeryGlioma
Details
IL13Rα2 targeted CAR-T cell(Yooyoung)YYB-103; CLM-103Phase 1 ClinicalYooYoung Pharmaceutical Co LtdAmyotrophic Lateral Sclerosis; Glioma
Details
Autologous TGF-betaR2KO/IL13R-alpha2-CAR T cells Therapy(City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical CenterAstrocytoma; Glioblastoma
Details
MT-026MT-026Phase 1 ClinicalT-Maximum Pharmaceutical (Suzhou) Co LtdGlioma
Details
SNC-109SNC109; SNC-109Phase 1 ClinicalShanghai Simnova Biotechnology Co LtdGlioblastoma
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques